Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-003559
Filing Date
2025-02-07
Accepted
2025-02-07 16:09:51
Documents
1
Period of Report
2025-02-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2842
  Complete submission text file 0001127602-25-003559.txt   4594
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1250 5TH AVENUE SOUTH NAPLES FL 34102
Business Address
THULIN INGE G (Reporting) CIK: 0001263739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 25601788